ISTANBUL: In a major medical breakthrough, Japanese researchers have developed a new skin cancer treatment based on a genetically modified virus, marking a significant advance in the field of cancer therapy.
According to a report by Japan’s public broadcaster NHK, scientists from the University of Tokyo and Shinshu University collaborated to create a viral-based therapy that targets and destroys cancer cells. The experimental drug harnesses a specially engineered virus that selectively replicates within cancer cells, leaving healthy cells unharmed.
This innovative approach, known as viral therapy, was tested on patients suffering from an aggressive form of skin cancer. The virus was administered alongside conventional treatments to determine its effectiveness. The results were promising: seven out of nine patients (77.8%) showed measurable improvement after receiving the combination therapy.
Continue reading with Eandel
Subscribe to unlock the complete story and receive your subscriber benefits.